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expression of SOCS1 and its potential regulatory microRNAs (miRNAs) in leukocytes is corre-
lated to the development of dengue haemorrhagic fever (DHF).
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in leukocytes for patients with DF and DHF in a DENV-2 outbreak that occurred in Taiwan be-
tween 2002 and 2003. We performed reverse transcription polymerase chain reaction to eval-
uate the expression of SOCS1 and its regulatory miRNAs in mononuclear leukocytes obtained
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miR-150 reduces SOCS1 levels in dengue haemorrhagic fever 367Results: SOCS1 expression and lower IFN-g level were significantly reduced in DHF patients,
but not in patients with DF. Elevated SOCS1 and reduced miR-150 levels were detected 24 h
after DENV-2 infection in PBMCs. Transfection of a miR-150 mimic into CD14þ cells infected
with DENV-2 suppressed the induction of SOCS1 expression in a dose-dependent manner.
Conclusion: We demonstrate for the first time that augmented miR-150 expression with
depressed SOCS1 expression in CD14þ cells are associated with the pathogenesis of DHF.
ª 2014 The Authors. Published by Elsevier Ltd on behalf of the The British Infection
Association. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Dengue fever (DF) is transmitted by mosquito bites that
introduce dengue virus (DENV) serotypes 1e4. DF is
endemic in tropical and subtropical regions, with at least
50 million new cases arising each year.1 Dengue haemor-
rhagic fever (DHF) and dengue shock syndrome (DSS), the
severe forms of DF, affect people in nearly two-thirds of
the countries worldwide, particularly those in Southeast
Asia.2 DENV serotype 2 (DENV-2) is a risk factor associated
with DSS, whereas DENV-1, DENV-3, and DENV-4 are not.3
Patients who develop DHF initially present symptoms
similar to DF patients, but they abruptly develop plasma
leakage, which manifests as haemoconcentration, ascites,
and pleural effusion, and may result in irreversible DSS dur-
ing the defeverence stage.4
The pathogenesis of DHF is not fully understood, but an
alteration of T helper (Th)1/Th2 immune reaction is thought
to be involved.5 Early in DHF, a cascade of cytokines initiates
a series of events that lead to a shift from a Th1-type
response inmild DF to a Th2-type response resulting in severe
DHF.5 Th1/Th2 polarisation is regulated by the induction of
interleukin (IL)-10 and IL-12 by monocytes and monocyte-
derived dendritic cells (DCs). Moreover, monocytes/macro-
phages express CD14, a documented DENV receptor; play a
critical role in determining the balance of Th1/Th2 responses
by modulating IL-12 production.6e8 During the innate im-
mune response, monocytes, macrophages, and DCs secrete
numerous cytokines, a negative regulatory factors, including
suppressor of cytokine signalling 1 (SOCS1), are needed to
alleviate the series of cytokine cascade.
SOCS proteins have been implicated in the control of the
Th1/Th2 polarisation balance and cytokine signalling.9 In
addition, SOCS proteins positively and negatively regulate
the activation of antigen presenting cells and are essential
for T-cell development and differentiation.9 Macrophages,
DCs, and fibroblasts from Socs1/ mice produce increased
levels of pro-inflammatory cytokines, such as tumour ne-
crosis factor-a (TNF-a) and IL-12, in response to Toll-like re-
ceptor (TLR) signalling.10 SOCS1-mediated repression of IL-
4/STAT6 signalling in Th1 cells regulates interferon g (IFN-
g) production.9 SOCS-1 is a negative regulator of IL-4-
dependent pathways in vitro and has been reported to be
importance in Th2 immunity-associated traits, such as
immunoglobulin E, IL-13 induction, and allergic asthma.11
Overexpression of SOCS1 in Th2 cells represses STAT6 acti-
vation, while depletion of SOCS1 by using an antisense
SOCS1 cDNA construct induces constitutive activation of
STAT6.12 Given the facts that SOCS1 can regulate Th1 reac-
tion and augmented Th2 immune response has beenproposed to be a hallmark of DHF, we monitor whether
DHF have altered SOCS-1 expression, resulting in a skewed
Th1/Th2 cytokine production.
MicroRNAs (miRNAs) are small regulatory RNAs approxi-
mately 22 nucleotides (nt) in length. They are typically
derived from a single arm of imperfect, w80-nt RNA
hairpins, referred to as primary miRNAs that are located
within polymerase II-derived transcripts. Recently, hun-
dreds of small, non-coding miRNAs have been identified in
worms, flies, fish, frogs, mammals, and flowering plants
usingmolecular cloning and bioinformatics-based prediction
strategies.13,14 These miRNAs are transcribed from specific
miRNA genes present throughout the genome as indepen-
dent transcriptional units, or they can be produced during
intron processing of certain mRNAs.14 MicroRNAs are known
to regulate cytokine production,15e17 however, whether
miRNAs regulate SOCS1 expression during the DENV
infection-induced inflammatory response resulting in the
development of DHF is not known. We sought to determine
whether SOCS1 is involved in the development of DHF and
whether certain miRNAs regulate SOCS1 expression during
dengue infection and its development into DHF. To achieve
this, we performed reverse transcriptase polymerase chain
reaction (RT-PCR) to evaluate the expression of SOCS1 and
its potential regulatory miRNAs in mononuclear leukocytes
derived from patients with and without DHF.
Materials and methods
Subjects and study design
This study was reviewed and approved by the Institutional
Review Board of Kaohsiung Chang Gung Memorial Hospital,
Taiwan (Document No.: 97-0072B). We previously reported
that patients with DHF were significantly associated with
secondary DENV-2 infections and augmented Th2 cytokine
responses in a hospital-based caseecontrol study in the
DENV-2 outbreak that occurred in Taiwan between 2002 and
2003.18,19 Blood samples were drawn from the study partic-
ipants between 1 and 3 day after individuals were admitted
to the Kaohsiung Chang Gung Memorial Hospital. We ob-
tained blood samples from one patient with DHF, from
the same number of patients with classic DF, from those
with other non-dengue febrile illness (OFI, presumed to
be viral illness). Forty-one RNA samples from patients
without or with confirmed DENV-2 infection (15 DF, 14
DHF, and 12 OFI patients) were reverse-transcribed into
cDNA. Using these cDNA samples, we investigated whether
SOCS1 expression levels correlated with the severity of DF
and the expression of its regulatory miRNA. DENV-2
368 R.-F. Chen et al.infection was confirmed by the presence of clinical dengue
symptoms, the detection of DENV-2 RNA by using quantita-
tive RT-PCR in the blood samples. As we previously
described, the diagnosis of DHF was made according to
the criteria of the World Health Organization, which
included the presence of thrombocytopaenia (<100,000/
mm3), haemorrhage, and evidence of plasma leakage, as
indicated by haemoconcentration (20%), pleural effusion,
ascites, and/or hypoalbuminaemia.20,21 The OFI patients
were identified as those who had a fever but no detectable
DENV-specific immunoglobulin M or DENV RNA in leuko-
cytes, and no obvious bacterial aetiology for their illness.
Thus, these patients were presumed to have a non-
dengue viral illness.20,21
Screening for miRNA expression by using stem-loop
reverse transcription and TaqMan real-time RT-PCR
Total RNA was isolated from peripheral blood mononuclear
cells (PBMCs) using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions.
Stem-loop RT-PCR analysis of miRNA expression was per-
formed as described previously.22 All reagents were ob-
tained from Applied BioSystems (Foster City, CA, USA).
Briefly, 50 ng of total RNA was reverse-transcribed into
cDNA by using stem-loop primers and the TaqMan microRNA
Reverse Transcription kit. miRNA expression was quantified
using the Applied BioSystems 7500 Real-time PCR System
and the TaqMan Universal PCR Master Mix. We searched
for miRNA-targeted genes in an online public database sys-
tem, including miRBase Targets (http://microrna.sanger.
ac.uk/), and TargetScan (http://www.targetscan.org)
data analysis.23 Eleven miRNAs (miR-15a, miR-20, miR-21,
miR-96, miR-126, miR-146, miR-150, miR-181a, miR-155,
miR-221, and miR-572) were identified as potential regula-
tors of SOCS1 expression (Fig. 3(a)). To compare the levels
of miRNA expression, we normalised their expression to
that of the internal control 5S rRNA. Comparative threshold
(Ct) values were used to calculate the relative miRNA
expression. The amount of each miRNA relative to 5S
rRNA was calculated using the equation 2DCt, where
DCt Z (CtmiRNA  Ct5S). The PCR reactions were run at
95 C for 15 min followed by 40 cycles of denaturing at
95 C for 10 s and annealing/extension at 60 C for 60 s.
All reactions were performed in triplicate.
Real-time quantitative RT-PCR analysis of SOCS1
expression by using the SYBR Green PCR method
Using MultiScribe reverse transcriptase (PE Applied Bio-
Systems, Foster, CT) and random hexamer primers, mRNA
was synthesised into complementary DNA (cDNA) from
equal amounts of total RNA (100 ng) that was extracted
from PBMCs, according to the manufacturer’s protocol. The
cDNAs were subsequently amplified and quantified using
SYBR Green PCR reagents (RealQ-PCR Master Mix Kit,
Ampliqon, Copenhagen, Denmark) according to the manu-
facturer’s instructions. Briefly, the cDNA for the SOCS1 and
b-actin genes were amplified using AmpliTaq Gold DNA
polymerase and gene-specific primers that were designed
using Primer Express software (Applied BioSystems). Theprimers for SOCS1 were 50-CCC TGG TTG TTG TAG CAG CTT-
30 and 50-CAA CCC CTG GTT TGT GCA A-30, and the primers
for b-actin (internal control) were 50-GGC CAA CCG CGA
GAA GAT-30 and 50-CGT CAC CGG AGT CCA TCA C-30. Each
PCR reaction mixture (final volume 20 mL) contained the
following components: 2 mL of cDNA, 1 mL of 10 mM forward
primer, 1 mL of 10 mM reverse primer, 10 mL of 2 SYBR
Green PCR Master Mix, and 6 mL of H2O. The PCR reactions
were performed in triplicate. The relative quantification
values for the target gene expression were calculated
from the Ct values, the PCR cycle at which fluorescence
from the SYBR Green dye exceeded that of the baseline
signal. To calculate DCt, Ct values for b-actin cDNA were
subtracted from that of the target cDNA. Three DCt values
for each sample were averaged. To calculate the fold-
change of SOCS1 expression in cells treated with the miR-
150 mimic relative to that of control cells, the average
DCt value calculated for the control cells was subtracted
from that calculated for the miR-150 transfected cells,
generating the DDCt value. Next, the fold-change for
each well was calculated using the 2DDCt formula. The
fold-change values from three wells were averaged.19,22
Measurement of plasma Th1/Th2 cytokine levels in
DHF and DF patients
Plasma levels of IFN-a, IFN-g, IL-10, and IL-13 were
measured using enzyme-linked immunosorbent assay
(ELISA) kits manufactured by Bender MedSystems Inc.,
Vienna, Austria. The results were calculated from the
interpolation of a standard curve made from a series of
known concentrations of commercial standards.
Preparation of DENV-2
DENV-2 (New Guinea C strain) was propagated in Aedes al-
bopictus C6/36 cells. Virus titres were determined by a
standard plaque-forming assay using BHK-21 cells. Titres
were adjusted to 2  107 PFU/ml in RPMI 1640 medium
(Gibco BRL, Grand Island, NY, USA) containing 10% foetal
calf serum (Gibco BRL) in a large-scale preparation. Viruses
were collected and stored at 80 C before use.
Preparation of peripheral blood mononuclear cells
and CD14D cells
Human PBMCs were prepared and collected from whole-
blood donated from healthy, seronegative, consenting
donors by using a DENV antibody detection kit (Gene Labs
Diagnostics, Singapore). Blood samples were mixed with
4.5% dextran to separate leukocytes from red blood cells.
PBMCs were separated from polymorphonuclear cells by
using FicollePaque density centrifugation, and were resus-
pended to a concentration of 2  106 cells/mL. CD14þ cells
were isolated by positive selection using CD14 microbeads
and a magnetic cell separator (Miltenyi Biotech, Inc.,
Auburn, CA, USA) according to the manufacturer’s specifi-
cations. The purity of monocytes isolated using this proce-
dure was greater than 95%, as measured using flow
cytometry (FACScalibur, Becton Dickinson, San Jose, CA,
USA) following a procedure described previously.22 106
Table 1 Demographic data for study-participating dengue patients afflicted with DHF or DF.
DF DHF P values
N Z 15 N Z 14
Age (years) 54 (40e57) 53 (30.5e68.3) 0.942
Gender (M/F) 5/10 7/7 0.362
White blood cells count (cell/mm3) 3550 (2250e6220) 7900 (5200e9500) 0.036
Haematocrit (%) 37.5 (35.1e39.6) 42.6 (42.0e45.4) 0.022
Platelet count (104/mm3) 6.3 (1.7e19.4) 1.3 (0.8e2.2) 0.007
Serum albumin level (g/dL) 3.6 (3.5e3.8) 2.9 (2.7e3.2) 0.008
Serum AST level (U/mL) 96 (58e157) 135 (36e325) 0.429
Serum ALT level (U/mL) 51 (35e60) 96 (52e268) 0.286
Pleural effusion (%) 0 (0%) 10 (71%) <0.001
Ascites (%) 0 (0%) 8 (57%) 0.001
Duration of fever (days) 3.0 (2.0e7.0) 5 (4.0e6.5) 0.408
Duration of hospitalization (days) 4.0 (3.0e5.0) 7.5 (5.0e14.0) 0.008
The results were expressed as median (interquartile range (IQR)) values; P values were determined by application of Mann Whitney U
test for continuous variables and by c2 test for categorical variables.
Figure 1 Suppressor of cytokine signalling 1 (SOCS1) mRNA expression in peripheral mononuclear cells (PBMCs) and Th1/Th2 cy-
tokines derived from patients with and without dengue haemorrhagic fever (DHF). (a) RNA samples collected from patients with DF
(-, n Z 15), DHF (:, n Z 14), and other febrile illnesses (OFI,C , n Z 12), were subjected to SYBR Green real-time reverse
transcription polymerase chain reaction (RT-PCR) analysis (P Z 0.065, 0.009, respectively). (b) Plasma IFN-g and IL-10 in patients
with DF and DHF by ELISA (Mann Whitney U test, P Z 0.033 and 0.046, respectively). Median and interquartile range are shown.
Circles and squares indicate individual values.
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Figure 2 SOCS1 mRNA expression induced by dengue virus
serotype 2 (DENV-2) infection in PBMCs. Induction of SOCS1
mRNA expression in PBMCs was detected using real-time RT-
PCR in 10 caseecontrol samples with and without DENV-2 infec-
tion after 24 h (a). CD14þ cells expressed SOCS1 mRNA after
DENV-2 infection (b). Elevated levels of SOCS1 expression
were significantly associated with DENV-2 infections in PBMCs,
particularly in CD14þ cells (P Z 0.002, <0.001, respectively).
370 R.-F. Chen et al.CD14þ cells per well are seeded into 1-ml culture medium
in triplicates in 24-well tissue-culture plates and incubated
at 37 C in humidified 5% CO2 atmosphere in the presence or
absence of DENV-2 infection. Samples were analysed in two
independent triplicate experiments.
Transfection of miR-150 mimic molecules into
CD14D monocytes
The miR-150 mimic molecules and negative control miRNAs
were purchased from Thermo Scientific Dharmacon Inc.
(Chicago, IL, USA) and were separately transfected into
CD14þ cells at a concentration of 20 nmol/L by using Oligo-
fectamine (Invitrogen) according to the manufacturer’s in-
structions. CD14þ monocytes (2  105 cells) that were
purified (>95%) using the AutoMACS bead separator (Milte-
nyi Biotec, Bergisch Gladbach, Germany) were transfected
with 60 pmol of miRNA mimic using 3 mL of Oligofectamine
in serum-free RPMI 1640 medium for 4 h. Afterwards, the
cells were placed in fresh RPMI medium supplemented
with 10% foetal bovine serum and cultured. The protocol
used to transfect the miR-150 mimic into CD14þ monocytes
was optimised by an efficient transfection of 80e90% GFP
fluorescence using cytoplasmic GFP-mRNA detection with
a cell viability of more than 80% by using the MTT assay.
CD14þ cells transfected with miR-150 or negative control
miRNAs were harvested 24 h after transfection. Control
cells and those infected with DENV2 were harvested 24 h af-
ter infection. MiR-150 expression was analysed using RT-
PCR as described in the previous section.
Data and statistical analyses
Data from the clinical demography, SOCS1 and Th1/Th2
cytokines for dengue patients were expressed as median
(interquartile range (IQR)) values. Data from PBMCs were
presented as the mean  standard error. We used the Mann
Whitney U test for statistical comparisons made between
continuous variables and c2 analyses were used for compari-
sons made between categorical variables. A P value <0.05
wasconsidered statistically significant.All analyseswereper-
formed using SPSS 13.0 software (SPSS Inc. Chicago, IL, USA).
Results
Demographic data for patients with DHF and DF
During a large DENV-2 outbreak in southern Taiwan between
August 2002 and March 2003, we recruited 41 patients with
suspected DENV-2 infections who were admitted to our
hospital to participate in this study. Our study featured a
complicated versus uncomplicated caseecontrol design.
Twenty-nine of the 41 patients were shown to be infected
with DENV-2 by using real-time quantitative RT-PCR. The age
of the patients studied ranged from 7 to 79 years. Of the 29
patients studied, 14 were diagnosed with DHF and 15 were
diagnosed with DF. Ten of the 14 DHF patients had mild DHF
(grades I/II) and the other 4 DHF patients had severe DHF
(grades III/IV). The main characteristics of the study popu-
lation are summarised in Table 1. No significant differenceswere observed between the patients with DHF and those
with DF with respect to age, sex, serum levels of alanine
aminotransferase, and aspartate aminotransferase, or dura-
tion of fever. Total leukocyte counts, haematocrit levels,
platelet counts, serum levels of albumin, plasma leakage
(pleural effusion and ascites), and duration of hospitalisa-
tion differed significantly different between patients with
DHF and those without DHF (Table 1).
Defective SOCS1 expression with a skewed Th1/Th2
cytokine production in patients with dengue
haemorrhagic fever
Because SOCS1 is a crucial regulator of IL-12-mediated IFN-
g production,9 we determined the expression level of
SOCS1 in PBMCs derived from OFI and patients with DHF
or DF by using a real-time quantitative RT-PCR assay.
Results showed that SOCS1 expression was elevated in DF
patients, but not in those with DHF (Fig. 1(a)). In addition,
miR-150 reduces SOCS1 levels in dengue haemorrhagic fever 371we assessed IFN-g and IL-10 levels in blood to reflect the
change of Th1/Th2 profiles related to severity. It was found
that patients with DF elicited a higher IFN-g production
than those with DHF (PZ 0.033, Fig. 1(b)). In contrast, pa-
tients with DHF had a higher IL-10 level than those with DF
(PZ 0.046, Fig. 1(b)). There were no difference in the IFN-
a and IL-13 levels between patients with DF and DHF (data
no showed).
Induction of SOCS1 mRNA expression by DENV-2
infection in PBMCs particular in CD14D cells
To further determine whether DENV-2 infection could
induce SOCS-1 expression in vitro, we examined both of
DENV-2 viral load and SOCS-1 expression in mRNA level of
PBMCs isolated from healthy subjects at 12e48 h postinfec-
tion and at a multiplicity of infection (MOI) of 1, 5, and 10,
respectively. We determine the viral titre both in at 12, 24
and 48 h postinfection and in MOIZ 1, 5, and 10 by the Taq-
Man RT-PCR assay. The detected DENV-2 titres were related
to the time course and dose dependent (data not shown). A
significant increase in SOCS1 expression was induced in the
primary DENV-2 infection in PBMCs from healthy individuals
at 24 h postinfection (n Z 6, P Z 0.002, Fig. 2(a)). To
further determine what population of PBMCs induce the
SOCS-1 expression, we found that CD14þ cells isolated by
positive selection using CD14 microbeads were infected
with DENV-2 at an MOI of 5, had significantly elevated
SOCS1 expression, whereas CD14e cells did not (n Z 6,
P < 0.001, Fig. 2(b)).Figure 3 Candidate miRNA sequences on 30-untranslated region
(TargetScanS) (a). In 20 pairs of PBMC samples with and without
and miR-572 were down-regulated in patients with DHF (P Z
(P Z 0.008).Expression of miRNAs in patients with DF and DHF
To determine which miRNAs were associated with DF or
DHF, we initially screened 20 pairs of PBMC samples for 11
miRNAs that were potential regulators of SOCS1 based on
bioinformatics-based analysis of the SOCS1 mRNA 30 un-
translated region (30 UTR) (Fig. 3(a)). Using real-time RT-
PCR, we analysed the expression levels of miR-150, 181a,
155, 221, and 572 in the PBMCs of DF and DHF patients
(Fig. 3(b)). The expression levels of miR-221 (2.82-fold;
P Z 0.021) and miR-572 (4.60-fold; P Z 0.012) in patients
with DF were significantly higher than in DHF patients.
Only miR-150 was expressed at elevated levels in DHF sam-
ples (7.16-fold; P Z 0.008).
Reciprocal relationship of SOCS1 and miR-150
expression in DENV-2-infected PBMCs
We tested whether SOCS1 mRNA expression was inversely
correlated to miR-150 expression in patients with DHF. In
PBMCs derived from patients with DHF, reduced SOCS1
expression was significantly associated with up-regulated
miR-150 levels (Fig. 4(a)). We determined whether miR-150
and SOCS1 mRNA levels were reciprocally regulated in
DENV-2-infected PBMCs. DENV-2 infection induced the
expression of SOCS1 after 24 h, and this was inversely corre-
lated to the levels of miR-150 expression (Fig. 4(b)).
To demonstrate that miR-150 specifically down-regulated
SOCS1 expression, we transfected a miR-150 mimic into
CD14þ cells and assessed the reciprocal relationship(UTR) of SOCS1 were identified using a target-finding program
DHF, the expression of 11 miRNAs was screened. (b). miR-221
0.021, 0.012, respectively) and miR-150 was up-regulated
372 R.-F. Chen et al.betweenmiR-150 and SOCS1 expression. Control CD14þ cells
and those transfected with miR-150 for 24 h were infected
with DENV-2 at an MOI of 5 in 24-well plates for 4 h, and
then the expression of miR-150 and SOCS1 was assessed.
Overexpression of miR-150 suppressed the DENV-2-induced
expression of SOCS1 in a dose-dependent manner (Fig. 4(c)).Figure 4 Reciprocal relationship of SOCS1 and miR-150
expression in DENV-2-infected PBMCs. Real-time RT-PCR
showed that miR-150 and SOCS1 mRNA expression in patients
with DF (a) and in PBMCs infected with DENV-2 (b) had an in-
verse relationship. Transfection of miR-150 mimic into CD14þ
cells for 24 h was performed to confirm that miR-150 regulated
SOCS1 expression in DENV-2-infected cells. Overexpression of
miR-150 suppressed the DENV-2-induced expression of SOCS1
in a dose-dependent manner (c).Discussion
The outcomes of DENV infections are dictated by a myriad
of interactions between viral, immunological, and human
genetic factors, as well as kinetic interactions between
innate and adaptive immunity. The theory of viral virulence
versus secondary immune enhancement in the pathogenesis
of DENV infections has been a matter of debate for many
years.24,25 Our group19,26 and others27 have previously
shown that viral load is not significantly associated with
DHF. Thus, the underlying mechanism of DHFV pathogenesis
might be related to activation of virus-infected leukocytes,
resulting in alteration of cytokine induction. In this study,
we provide the first evidence showing that the suppression
of SOCS-1 expression was correlated to augmented miR-150
expression in patients with DHF and in CD14þ monocytes in-
fected with DENV-2.
The SOCS proteins are key negative regulators of
cytokine signalling and the Janus kinase (JAK)/signal trans-
ducer and activator of transcription (STAT) signalling
pathway.28 Production of SOCS1 proteins may be induced
by a wide range of stimuli, including lipopolysaccharide
(LPS), TNFa, IL-6, and transforming growth factor b (TGF-
b).29,30 Several reports link SOCS1 to the dysregulation of
cytokine. SOCS1-deficient mice are hypersensitive to LPS,
leading to an increase in TNFa and IL-12 production.31,32
Several mechanisms have been proposed for the suppres-
sion of cytokine production by SOCS1. An important mech-
anism for the suppression of macrophage activation is
SOCS1-mediated inhibition of the secondarily activated
JAK/STAT pathway.33 Wang et al.34 report that vesicular
stomatitis virus-mediated induction of miR-155 occurred
through a retinoic acid-inducible gene I/JNK/nuclear factor
kB-dependent mechanism. Up-regulated miR-155 sup-
pressed SOCS1 expression in macrophages and subsequently
enhanced type I IFN effector gene expression, thereby sup-
pressing viral replication. Notably, SOCS1 is also a tumour
suppressor. Jiang et al.35 showed that miR-155 is up-
regulated in breast cancer cells, contributing to the post-
transcriptional silencing of SOCS1 and the constitutive acti-
vation of STAT3. In this study, we demonstrated that pa-
tients with DHF had reduced SOCS1 expression and
elevated miR-150 levels. The miR-155 expression was
observed in patients with DF, but not in patients with DHF
(Fig. 3(b)).
MicroRNAs are an abundant class of highly conserved
small non-coding RNAs. They primarily function through
suppressing the expression of target genes by binding to
their 30-UTRs of target mRNAs inducing mRNA degradation
or suppressed translation. MicroRNAs have been shown to
regulate a variety of biological processes including devel-
opment, cell proliferation, differentiation, apoptosis,36,37
and viral infections.38,39 The role of miRNAs in the regula-
tion of innate immunity was first reported by Taganov
et al.,40 who showed that miR-146 is a negative feedback
regulator of TLR signalling. We have previously reported
that low innate miR-21 expression, resulting in high TGF-b
receptor 2 expression, correlates to antenatal IgE produc-
tion and development of allergic rhinitis.22 In this study,
we found that miR-21 was not associated with dengue in-
fections, but miR-150 was significantly associated with
miR-150 reduces SOCS1 levels in dengue haemorrhagic fever 373DHF. miR-150 has been found to be highly expressed in im-
mune cells, and has a permissive function in the matura-
tion, proliferation and differentiation of myeloid and
lymphoid cells.41 Many of the miR-150 target transcripts
identified so far are pro-apoptotic and differentiation pro-
teins, such as early growth response 2 (EGR2), c-myb, and
notch homologue 3 (NOTCH3).42e44 Aberrant methylation
of the SOCS-1 occurs in hepatocellular carcinoma45 and
Gfi-1, a transcription repressor, was also approved binding
on SOCS1 gene promoter and regulated SOCS1 expression.11
Here, we identified SOCS1 as a possible target of miR-150 in
human CD14þ cells and confirmed that miR-150 down-regu-
lates SOCS1 expression levels in DENV-2-infected cells
(Fig. 4(c)).
SOCS1 expression levels are reported to increase rapidly
following macrophage exposure to inflammatory cytokines
and TLR ligands.46,47 We showed that SOCS1 mRNA expres-
sion increased in CD14þ cells in response to DENV-2 infec-
tion (Fig. 4(b)). SOCS1 protein level is more critical than
mRNA expression; however, we were unable to determine
the protein level from the DENV-2 cohort due to the limi-
tations of remnant specimens. Further studies are required
to determine whether other miRNAs or SOCS family pro-
teins are involved in the pathogenesis of DHF.
In summary, we found that patients with DHF had
elevated miR-150 expression, which was associated with
the suppression of SOCS1 expression. The overexpression of
miR-150 suppressed SOCS1 expression, confirming that
SOCS1 expression is regulated by miR-150. These data
highlight that abnormal immune responses in patients
with DHF can be potentially controlled by modulating
miRNA expression.
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